Management of psychiatric adverse events with immunotherapy with interferon-alfa.

about

Minding the body: psychotherapy and cancer survival.Interferon, tryptophan and depression.

P2860

Q38131803-E2FF7506-9749-4D8F-86D8-A4E83A54B338 Q38777707-097EB0E4-3E8C-4DB3-B84E-BA28FF5194F4

P2860

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

Item

http://www.wikidata.org/entity/Q35956876

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年論文

@yue

1999年論文

@zh-hant

1999年論文

@zh-hk

1999年論文

@zh-mo

1999年論文

@zh-tw

1999年论文

@wuu

1999年论文

@zh

1999年论文

@zh-cn

name

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@ast

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@en

type

Item

label

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@ast

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@en

prefLabel

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@ast

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@en

P1476

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

@en

P2093

A M Eggermont

http://www.w3.org/2001/XMLSchema#string

A R Van Gool

http://www.w3.org/2001/XMLSchema#string

J J Cornelissen

http://www.w3.org/2001/XMLSchema#string

L Berk

http://www.w3.org/2001/XMLSchema#string

M Bannink

http://www.w3.org/2001/XMLSchema#string

W H Kruit

http://www.w3.org/2001/XMLSchema#string

P2860

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684.

Clinical toxicity of the interferons.

Side effects of alpha interferon in chronic hepatitis C.

Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5 mm without clinically detectable node metastases. French Cooperative Group on Melanoma.

Psychiatric complications of long-term interferon alfa therapy.

P304

120-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0924270800035857

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Eggermont

P577

1999-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26976539

http://www.w3.org/2001/XMLSchema#string

P921

immunotherapy

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

about

P2860

P2860

Management of psychiatric adverse events with immunotherapy with interferon-alfa.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921